COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis

Heart Failure (HF) patients are at a higher risk of adverse events associated with Coronavirus disease 2019 (COVID-19). Large population-based reports of the impact of COVID-19 on patients hospitalized with HF are limited. The National Inpatient Sample database was queried for HF admissions during 2020 in the United States (US), with and without a diagnosis of COVID-19 based on ICD-10-CM U07. Propensity score matching was used to match patients across age, race, sex, and comorbidities. Multivariate logistic regression analysis was used to identify predictors of mortality. A weighted total of 1,110,085 hospitalizations for HF were identified of which 7,905 patients (0.71%) had a concomitant diagnosis of COVID-19. After propensity matching, HF patients with COVID-19 had higher rate of in-hospital mortality (8.2% vs 3.7%; odds ratio [OR]: 2.33 [95% confidence interval [CI]: 1.69, 3.21]; P< 0.001), cardiac arrest (2.9% vs 1.1%, OR 2.21 [95% CI: 1.24,3.93]; P<0.001), and pulmonary embolism (1.0% vs 0.4%; OR 2.68 [95% CI: 1.05, 6.90]; P = 0.0329). During hospitalizations for HF, COVID-19 was also found to be an independent predictor of mor-tality. Further, increasing age, arrythmias, and chronic kidney disease were independent predictors of mortal-ity in HF patients with COVID-19. COVID-19 is associ-ated with increased in-hospital mortality, longer hospital stays, higher cost of hospitalization and increased risk of adverse outcomes in patients admitted with HF. (Curr Probl Cardiol 2023;48:101541.)

Automated summary

Heart Failure (HF) patients with COVID-19 have a higher rate of in-hospital mortality, cardiac arrest, and pulmonary embolism compared to HF patients without COVID-19. COVID-19 is an independent predictor of mortality during hospitalizations for HF. Increasing age, arrythmias, and chronic kidney disease are also independent predictors of mortality in HF patients with COVID-19. COVID-19 is associated with increased in-hospital mortality, longer hospital stays, higher cost of hospitalization, and increased risk of adverse outcomes in patients admitted with HF.